Our lab seeks to discover drug targets by applying genetic screens to human cancer cells. This genetic screening campaign has overwhelmingly led us to DNA-binding transcription factors as an opportunity for developing new medicines in oncology. To develop pharmacology against these challenging targets, we apply the latest innovations in high-throughput genetics, biochemistry, genomics, and structural biology to gain deep insights into cancer-promoting transcriptional mechanisms.